Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France.

by Gregory Katz, Olivier Romano, Cyril Foa, Anne-Lise Vataire, Jean-Victor Chantelard, Robert Hervé, Hugues Barletta, Axel Durieux, Jean-Pierre Martin, Rémy Salmon
Published 2015-01-01

Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredic...

by Frédérique Penault-Llorca, Fabrice Kwiatkowski, Antoine Arnaud, Christelle Levy, Marianne Leheurteur, Lionel Uwer, Olfa Derbel, Annick Le Rol, Jean-Philippe Jacquin, Christelle Jouannaud, Nathalie Quenel-Tueux, Véronique Girre, Cyril Foa, Emmanuel Guardiola, Alain Lortholary, Stéphanie Catala, Séverine Guiu, Alexander Valent, Diane Boinon, Jérome Lemonnier, Suzette Delaloge
Published 2020-02-01

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.

by Delphine Hequet, Céline Callens, David Gentien, Benoit Albaud, Marie-Ange Mouret-Reynier, Coraline Dubot, Paul Cottu, Cyrille Huchon, Sonia Zilberman, Helene Berseneff, Cyril Foa, Rémy Salmon, Aurélie Roulot, Florence Lerebours, Anne Salomon, Nadeem Ghali, Pascale Morel, Qianyi Li, Anne Cayre, Jean-Marc Guinebretière, John Hornberger, Frédérique Penault-Llorca, Roman Rouzier
Published 2017-01-01